| Barany and Solid-Phase Peptide Synthesis
| [0047]
|
| J. Am. Chem. Soc.
| [0047]
|
| Solid Phase Peptide Synthesis
| [0047]
|
| Mini Rev. Med Chem.
| [0047]
|
| Protein Pept Lett.
| [0047]
|
| From Genes to Clones
| [0052]
|
| Immunol. Rev.
| [0052]
|
| J. Immunol.
| [0052]
|
| Remington's Pharmaceutical Sciences
| [0054]
[0056]
|
| J. Biomed. Mater. Res.
| [0058]
|
| Chem. Tech.
| [0058]
|
| Biopolymers
| [0058]
|
| Development of the endochondral skeleton [J
| [0130]
|
| Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts [J
| [0130]
|
| Does low bone mineral density start in postteenage years in women with type 1 diabetes [J
| [0130]
|
| Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance [J
| [0130]
|
| Diabetes and bone loss at the hip in older black and white adults [J
| [0130]
|
| The Investigation and evaluation of bone mineral density in type 2 diabetic women [J
| [0130]
|
| Molecular, endocrine, and genetic mechanisms of arterial calcification [J
| [0130]
|
| Usefulness of bone mineral density to predict significant coronary artery disease [J
| [0130]
|
| Aortic calcification and the risk of osteoporosis and fractures [J
| [0130]
|
| Title: Molecular perspectives of vitamin D in osteoblast and association between osteoporosis and artery calcification
| [0130]
|
| Vitamin D and aging: old concepts and new insights
| [0130]
|
| Extracellular matrix degradation
| [0130]
|
| Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator
| [0130]
|
| Tissue cooperation in a proteolytic cascade activating human interstitial collagenase
| [0130]
|
| Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
| [0130]
|
| A cellular binding site for the Mr 55, 000 form of the human plasminogen activator, urokinase
| [0130]
|
| Structural relationship between ''glutamic acid'' and ''lysine'' forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography
| [0130]
|
| Cell-associated plasminogen activation: regulation and physiological functions
| [0130]
|
| Synthesis of human plasminogen by the liver
| [0130]
|
| Biochemistry of plasminogen
| [0130]
|
| Amino-acid sequence of activation cleavage site in plasminogen: homology with ''pro'' part of prothrombin
| [0130]
|
| Basic and clinical aspects of fibrinolysis and thrombolysis
| [0130]
|
| Proteinases and extracellular matrix remodeling
| [0130]
|
| Biology and biochemistry of proteinases in tumor invasion
| [0130]
|
| Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling
| [0130]
|
| Growth factor control of extracellular proteolysis
| [0130]
|
| The urokinase-type plasminogen activator system in cancer metastasis: a review
| [0130]
|
| Proteolytic control of growth factor availability
| [0130]
|
| Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential [J
| [0130]
|
| Simplified recombinant plasmin: production and fu-nctional comparison of a novel thrombolytic molecule with plasma-derived plasmin [J
| [0130]
|
| The primary structure of human plasminogen: Isolation of two lysine-binding fragments and one ''mini''-plasminogen (MW, 38, 000) by elastase-catalyzed-specific limited proteolysis [J
| [0130]
|
| Recombinant human microplasmin: production and potential therapeutic properties [J
| [0130]
|
| Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization J
| [0130]
|
| Bone Resorption Induced by 1a,25 Dihydroxyvitamin D3 In Vivo Is Not Altered by Inactivation of the Plasminogen Activator Inhibitor 1
| [0130]
|
| Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process
| [0130]
|
| The correlation between bone histomorphometry and serum alkaline phosphatase in ovariectomized rats
| [0130]
|
| Perspective: The diagnosis of osteoporosis
| [0130]
|
| The application of the bone metabolic markers and bone mineral density in osteoporosis
| [0130]
|
| Arterioscler Thromb
| [0130]
|
| Npp1 promotes atherosclerosis in ApoE knockout mice
| [0130]
|
| Severe hyercholestrolemia and antherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
| [0130]
|
| Spontaneous hypeicholeserolemia and arterial leision in mice lacking apolipoprotrin E [J
| [0130]
|
| Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
| [0130]
|
| Interferon-g Plays a Role in Bone Formation In Vivo and Rescues Osteoporosis in Ovariectomized Mice
| [0130]
|
| Neuropeptide Y-based recombinant peptides ameliorate bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization
| [0130]
|
| Inhibitor of differentiation 3, a transcription factor regulates hyperlipidemia associated kidney disease
| [0130]
|
| Extracts of Rhizoma Polygonati Odorati Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice
| [0130]
|
| Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women
| [0130]
|
| Oxidized low density lipoprotein, stem cells, and atherosclerosis
| [0130]
|